FDA approves first sensor-enabled inhaler
July 17, 2019
Asthma patients may soon treat themselves with first-ever digital maintenance inhaler.
Recent Content
Overactive bladder drug not linked to CV events
July 17, 2019
Patients with overactive bladder taking this OAB drug did not experience an excess risk of CV events compared with other treatments.
EpiPen shortage: Pharma maker, retailer offer aid
July 16, 2019
EpiPens have been in short supply, but stakeholders are trying to fill in the access gap.
Experts debate drug pricing policies
July 16, 2019
While some are concerned that President Trump’s proposed “favored nations” policy would harm pharma makers, one analyst is not as concerned.
FDA warns opioid repackers
July 9, 2019
FDA warns opioid repackers for "significant violations."
FDA fast tracks blockbuster diabetes drug for heart failure
July 8, 2019
FDA granted Fast Track designation to a popular diabetes drug to reduce the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure.
Are certain anticholinergic meds linked to dementia risk?
July 2, 2019
The validity of a new large study linking anticholinergic drugs to the risk of dementia has stirred up controversy.
Cybersecurity glitch wreaks havoc on insulin pumps
July 1, 2019
FDA recalls insulin pumps due to cybersecurity miscommunication.
Top 4 drugs in the pipeline
June 24, 2019
A new report from OptumRx reveals the top 4 drugs in development for the second quarter of 2019.
Effects of female libido drug unknown, advocacy group warns
June 24, 2019
A women’s health organization is concerned about the safety and effectiveness of bremelanotide (Vyleesi) after FDA approved it to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.
